Most recently, the protective effects of H. diminuta infection, and of the myeloid population induced by the parasite, have been shown to be inhibited by IL-22, but promoted by IL-25, with disease scores in DNBS-induced colitis exacerbated by anti-IL-25 antibody treatment (142). The gene discussed is IL22; the disease is colitis.